Christoffer Røst Benneballe of Nordea argues Novo Nordisk needs the Wegovy pill as fresh pipeline growth while Eli Lilly's competition heats up.
Recap by typeshit. Post by Investseekers on X.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
Belga reports the number of seized weight loss drugs in Belgium went up again, with officials concerned about an unofficial parallel market.
BharatTechIND reports the drugmaker is widening its semaglutide lineup to get around supply problems with Obeda and grow in India's weight loss market.
Loading…